About Ind-Swift Laboratories
Ind-Swift Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India and internationally. The company operates through Bulk Drugs & Pharmaceuticals segment. It primarily offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, antimigraine, Parkinson disease, hyperparathyroidism, analgesic, aromatase inhibitor, nootropic, antihypertensive, antibacterial Quinolone, antidiarrhoeal, alcohol abstinence, antineoplastic, prostatic hyperplasia, and treatment of premature ejaculation; and others in glucocorticoids therapeutic area. The company also provides various products that are under development stage in prostatic hypertrophy, overactive bladder syndrome, and osteoporosis therapeutic areas. In addition, it offers menthol and mint derivatives under the Ind COOL brand. Further, the company provides contract research and manufacturing services, including early phase drug development, process research and development, custom chemical synthesis, contract and API manufacturing, and FTE, as well as analytical and regulatory submission support services. Ind-Swift Laboratories Limited was founded in 1995 and is based in Manimajra, India.